Significant Ownership of Enavate Sciences GP, LLC

Signature - Title
/s/ James P. Boylan - By James P. Boylan, Manager
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Enavate Sciences GP, LLC.

Notify me when Enavate Sciences GP, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Enavate Sciences GP, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ZBIO Zenas BioPharma, Inc. Common Stock, par value $0.0001 per share 7.3% $87,013,952 3,919,159 Enavate Sciences GP, LLC 09 Oct 2025
CAMP CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share 6% $13,729,110 -$2,890,560 3,127,360 -17% Enavate Sciences GP, LLC 19 Dec 2025
SION SIONNA THERAPEUTICS, INC. Common Stock, $0.001 par value per share 5.6% $29,835,481 2,478,030 Enavate Sciences GP, LLC 10 Feb 2025
IMNM IMMUNOME, INC. Common Stock, par value $0.0001 per share 4.3% $73,483,864 4,768,583 Enavate Sciences GP, LLC 18 Dec 2025

Schedules 13D/G Reported by Enavate Sciences GP, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.